Multiple myeloma, version 3.2021: NCCN Clinical Practice Guidelines in Oncology Guidelines
| Authors: | Kumar, S. K.; Callander, N. S.; Adekola, K.; Anderson, L.; Baljevic, M.; Campagnaro, E.; Castillo, J. J.; Chandler, J. C.; Costello, C.; Efebera, Y.; Faiman, M.; Garfall, A.; Godby, K.; Hillengass, J.; Holmberg, L.; Htut, M.; Huff, C. A.; Kang, Y.; Hultcrantz, M.; Larson, S.; Liedtke, M.; Martin, T.; Omel, J.; Shain, K.; Sborov, D.; Stockerl-Goldstein, K.; Weber, D.; Keller, J.; Kumar, R. |
| Title: | Multiple myeloma, version 3.2021: NCCN Clinical Practice Guidelines in Oncology |
| Abstract: | Multiple myeloma is a malignant neoplasm of plasma cells that accumulate in bone marrow, leading to bone destruction and marrow failure. This manuscript discusses the management of patients with solitary plasmacytoma, smoldering multiple myeloma, and newly diagnosed multiple myeloma. |
| Journal Title: | Journal of the National Comprehensive Cancer Network |
| Volume: | 18 |
| Issue: | 12 |
| ISSN: | 1540-1405 |
| Publisher: | Harborside Press |
| Date Published: | 2020-12-01 |
| Start Page: | 1685 |
| End Page: | 1717 |
| Language: | English |
| DOI: | 10.6004/jnccn.2020.0057 |
| PUBMED: | 33285522 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 4 January 2021 -- Source: Scopus |
